reddys

Business 

Pharma is in focus but there is no valuation comfort: Prabhudas Lilladher – Economic Times

September 20, 2020 anujratnam 0 Comments challenging, definitely, have, lupin, positive, recent, reddys, remains, The Times of India, valuation, very

‘We have a buy on Dr Reddys and Lupin. Dr Reddys definitely has a positive but the valuation remains very

Read more

Business 

Covid vaccine will be available in India by November, awaiting clearance: Russian Fund CEO – India Today

September 20, 2020 anujratnam 0 Comments dmitriev, exclusive, india, India Today, kirill, prasad, rdif, reddy, reddys, share, vaccine

Dr Reddy has partnered with Russian Development Investment Fund for the distribution of Russia’s Covid-19 Sputnik-V vaccine in India. RDIF

Read more

Business 

COVID-19 CURE: World’s First COVID-19 Vaccine “Sputnik-V” Is Expected To Be Available In India By November 2020. – Inventiva

September 19, 2020 anujratnam 0 Comments covid, director, first, Inventiva, laboratorygv, managing, ofdr, prasad, reddys, russias, vaccinesputnik

The managing director of Dr. Reddy’s laboratory GV Prasad said that Russia’s first COVID-19 vaccine Sputnik-V is expected to be available in India in

Read more

Business 

Dr Reddy’s US earnings to get a boost, but valuations are pricey – Mint

September 19, 2020 anujratnam 0 Comments laboratories, Livemint, market, open, opportunities, patent, post, reddys, regarding, revlimid, squibb

Dr Reddy’s Laboratories Ltd’s settlement with Celgene, a subsidiary of Bristol Meyers Squibb, regarding the Revlimid patent will open up

Read more

Business 

Dr Reddys reclaims spot as Indias 2nd most valuable pharma company – Business Standard

September 19, 2020 anujratnam 0 Comments 0217, Business Standard, crore, divis, laboratories, labs, market, reddys, stood, while

At 02:17 pm, Dr Reddy’s Labs market cap stood at Rs 90,348 crore while that of Divi’s Laboratories stood at

Read more

Business 

Pharma stocks today have their best day in over a month. Cipla, Dr Reddy’s surge – Mint

September 19, 2020 anujratnam 0 Comments cipla, closed, gains, index, Livemint, lupin, nifty, pharma, reddys

The Nifty Pharma index closed up 5%, led by gains in Dr Reddy’s, Cipla and Lupin

Read more

Business 

COVID-19 vaccine: Govt in talks with Russia for ‘possible advancement’ of Sputnik V in India – Mint

September 19, 2020 anujratnam 0 Comments clinical, conduct, deal, distribution, inked, laboratories, Livemint, reddys, russia, sputnik, trial

Russia was the first country in the world to register a COVID-19 vaccine.Earlier this week, Russian Direct Investment Fund inked

Read more

Business 

Dr Reddy’s Lab shares today hit new highs, extend weekly gains to 20% – Mint

September 18, 2020 anujratnam 0 Comments bristol, laboratories, litigation, Livemint, myers, reached, reddys, settled, squibbearlier, unit, week

Dr Reddy’s Laboratories said it has settled a litigation with a unit of Bristol Myers Squibb.Earlier this week, it had

Read more

General 

Russia, Dr Reddy’s tie up for Sputnik V trial – Times of India

September 17, 2020 anujratnam 0 Comments based, drug, fund, hyderabad, india, laboratories, maker, partnered, rdif, reddys, The Times of India

India News: Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) — has partnered Hyderabad-based drug maker Dr Reddy’s

Read more

General 

Russia to sell 100 million doses of Covid-19 vaccine to India – Times of India

September 16, 2020 anujratnam 0 Comments fund, india, indias, news, reddys, russias, sovereign, supply, The Times of India, wealth, wednesday

India News: Russia’s sovereign wealth fund said on Wednesday it will supply India’s Dr Reddy’s Laboratories with 100 million doses

Read more